Nerve Disorder Listed As ‘Very Rare’ Aspect Impress Of AstraZeneca Covid-19 Vaccine
Topline The European Medicines Agency (EMA) on Wednesday listed Guillain-Barre Syndrome—a neurological disorder that can cause transient paralysis—as a “very uncommon” facet place of the AstraZeneca Covid-19, a transfer that comes appropriate weeks after the nerve disorder was once listed…